Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA Editing in Cancer Progression
Valentina Frezza, Lidia Chellini, Arianna Del Verme, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5277-5277
Open Access | Times Cited: 12

Showing 12 citing articles:

Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Molecular mechanisms of non-genetic aberrant peptide production in cancer
Demi Wernaart, Amos Fumagalli, Reuven Agami
Oncogene (2024) Vol. 43, Iss. 27, pp. 2053-2062
Closed Access | Times Cited: 5
Exploring the Molecular Pathways of Advanced Rectal Cancer: A Focus on Genetic, RNA, and Biological Technique
Ameeduzzafar Zafar, Mohammad Khalid, Omar Awad Alsaidan, et al.
Pathology - Research and Practice (2025), pp. 155956-155956
Closed Access
A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC
Zhipeng Wang, Yan Wu, Ziqi Ding, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 180-180
Open Access | Times Cited: 5
Spatial Visualization of A-to-I Editing in Cells Using Endonuclease V Immunostaining Assay (EndoVIA)
Alexandria L. Quillin, B Arnould, Steve D. Knutson, et al.
ACS Central Science (2024) Vol. 10, Iss. 7, pp. 1396-1405
Open Access | Times Cited: 1
Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients
Zihan Zhu, Jing Lu
Medicine (2024) Vol. 103, Iss. 19, pp. e38116-e38116
Open Access
The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses
Wanqing Liu, Yufan Wu, Tong Zhang, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 52-69
Open Access
EndoVIA for quantifying A-to-I editing and mapping the subcellular localization of edited transcripts
Alexandria L. Quillin, B Arnould, Steve D. Knutson, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2024), pp. 99-130
Closed Access
Spatial visualization of A-to-I Editing in cells using Endonuclease V Immunostaining Assay (EndoVIA)
Alexandria L. Quillin, B Arnould, Steve D. Knutson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A-to-I Editing Is Subtype-Specific in Non-Hodgkin Lymphomas
Chen Cai, Ralf Bundschuh
Genes (2024) Vol. 15, Iss. 7, pp. 864-864
Open Access
Identification of prognostic RNA editing profiles for clear cell renal carcinoma
Weihong Chen, Shaobin Li, Dongqin Huang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Page 1

Scroll to top